Completed PHASE1 INTERVENTIONAL 2-arm NCT01338441

Selections of Subjects With Important Changes in Their Cardiac Repolarization Parameters for the Procurement of Skin and Blood Samples (iQTEST)

Selections of Subjects With Dramatic Changes in Their Cardiac Repolarization Parameters After a Pharmacologic Stimulus Aiming to Collect Their Skin Biopsy and Blood Cells

Sponsor: Ectycell SASU

Conditions Cardiology: RR / QT

Interventions Erythromycin Placebo

Updated 6 times since 2017 Last updated: Sep 14, 2011 Started: Mar 31, 2011 Primary completion: May 31, 2011 Completion: Aug 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Cardiology: RR / QT and is currently completed. Ectycell SASU leads this study, which shows 6 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Mar 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ectycell SASU
Institut National de la Santé Et de la Recherche Médicale, France
Pierre and Marie Curie University

Data source: Ectycell SASU

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Rueil-Malmaison, France